Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -8.92% vs -2.86% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -34.59% vs -11.69% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -49.72% vs 4.84% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 600.00% vs -83.33% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Zhejiang Xianju Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -1.62% vs -2.40% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -8.92% vs -2.86% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 59.44% vs -43.19% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -34.59% vs -11.69% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 95.34% vs -66.14% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -49.72% vs 4.84% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs -12.50% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 600.00% vs -83.33% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






